Pfizer Inc.
PFIZER INC. $42 (New York symbol PFE; Income Portfolio, Manufacturing & Industry sector; Shares outstanding: 5.8 billion; Market cap: $243.6 billion; Price-to-sales ratio: 4.6; Dividend yield: 3.4%; TSINetwork Rating: Above Average; www.pfizer.com) is one of the world’s largest makers of prescription drugs....
A: The ALPS Sector Dividend Dogs ETF, $43.27, symbol SDOG on New York (Units outstanding: 49.3 million; Market cap: $2.1 billion; www.alpssectordividenddogs.com), is an ETF that applies the “Dogs of the Dow” theory on a sector-by-sector basis using the stocks in the S&P 500....
We generally recommend investors avoid pharmaceutical companies due to the huge costs and risks of developing new drugs.
However, Pfizer is an exception. We feel its large size makes it less dependent on the success or failure of any single drug....
However, Pfizer is an exception. We feel its large size makes it less dependent on the success or failure of any single drug....
Here are two ETFs that emphasize value investing in their stock selection. Academic studies suggest that, on average, value stocks can produce better results than growth investing. Still, it’s important to look closely to see if they’re truly undervalued. They may, after all, only be cheap due to hidden problems.
At the same time, we think you benefit most from a balance of high-quality value stocks and growth stocks....
At the same time, we think you benefit most from a balance of high-quality value stocks and growth stocks....
LISTEN: 
ELI LILLY & CO. $105 (New York symbol LLY; Manufacturing & Industry sector; Shares outstanding: 1.1 billion; Market cap: $115.5 billion; Dividend yield: 2.1%; Takeover Target Rating: Low; www.lilly.com) develops, makes and markets drugs and animal-health products.
Lilly hopes to match the success Pfizer realized with its Zoetis spinoff (see pages 81 and 82) by setting up its Elanco Animal Health business as a separate company.
Using an initial public offering (IPO), Lilly will sell 20% of Elanco’s shares to the public....
Lilly hopes to match the success Pfizer realized with its Zoetis spinoff (see pages 81 and 82) by setting up its Elanco Animal Health business as a separate company.
Using an initial public offering (IPO), Lilly will sell 20% of Elanco’s shares to the public....
GLAXOSMITHKLINE PLC (ADR) $42 (New York symbol GSK; Manufacturing & Industry sector; ADRs outstanding: 2.5 billion; Market cap: $105.0 billion; Dividend yield: 3.8%; Takeover Target Rating: Low; www.gsk.com) is a U.K.-based global health-care company that develops, makes and sells products in three main markets: pharmaceuticals, vaccines and consumer health care....
Pfizer’s shares have gained 50% in the five years since it used an initial public offering to set up its animal-drug business as Zoetis. It then offered its remaining shares to investors. The new company now plans to sell or spin off its consumer business, which could push the stock even higher.
Zoetis, which has seen its shares triple since the split, should continue to profit from rising levels of pet ownership.
PFIZER INC....
Zoetis, which has seen its shares triple since the split, should continue to profit from rising levels of pet ownership.
PFIZER INC....
Rising interest rates mean dividend-paying stocks and fixed-income instruments must increasingly compete for investor interest. However, sustainable dividends still offer an attractive and growing income stream for investors (see supplement on page 50).
Here are four ETFs that provide exposure to Canadian, U.S....
Here are four ETFs that provide exposure to Canadian, U.S....
LISTEN: